ITRM960360A0 - Farmaco a base di un derivato della carnitina per il trattamento del= la demenza di alzheimer in pazienti ad insorgenza precoce della pato= logia. - Google Patents

Farmaco a base di un derivato della carnitina per il trattamento del= la demenza di alzheimer in pazienti ad insorgenza precoce della pato= logia.

Info

Publication number
ITRM960360A0
ITRM960360A0 ITRM960360A ITRM960360A ITRM960360A0 IT RM960360 A0 ITRM960360 A0 IT RM960360A0 IT RM960360 A ITRM960360 A IT RM960360A IT RM960360 A ITRM960360 A IT RM960360A IT RM960360 A0 ITRM960360 A0 IT RM960360A0
Authority
IT
Italy
Prior art keywords
dementia
alzheimer
patients
disease
treatment
Prior art date
Application number
ITRM960360A
Other languages
English (en)
Inventor
Menotti Calvani
Original Assignee
Menotti Calvani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menotti Calvani filed Critical Menotti Calvani
Publication of ITRM960360A0 publication Critical patent/ITRM960360A0/it
Priority to IT96RM000360A priority Critical patent/IT1284650B1/it
Priority to EP96830532A priority patent/EP0808626A1/en
Priority to TW086102135A priority patent/TW473388B/zh
Priority to KR1019970019692A priority patent/KR970073581A/ko
Priority to ZA9704506A priority patent/ZA974506B/xx
Priority to CA002205940A priority patent/CA2205940A1/en
Priority to JP9133289A priority patent/JPH1045582A/ja
Priority to MX9703810A priority patent/MX9703810A/es
Publication of ITRM960360A1 publication Critical patent/ITRM960360A1/it
Application granted granted Critical
Publication of IT1284650B1 publication Critical patent/IT1284650B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT96RM000360A 1996-05-24 1996-05-24 Farmaco a base di un derivato della carnitina per il trattamento della demenza di alzheimer in pazienti ad insorgenza precoce della patologia IT1284650B1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT96RM000360A IT1284650B1 (it) 1996-05-24 1996-05-24 Farmaco a base di un derivato della carnitina per il trattamento della demenza di alzheimer in pazienti ad insorgenza precoce della patologia
EP96830532A EP0808626A1 (en) 1996-05-24 1996-10-16 Use of acetyl-L-carnitine for the treatment of presenile Alzheimer's disease
TW086102135A TW473388B (en) 1996-05-24 1997-02-21 Pharmaceutical composition comprising a carnitine derivative for treating Alzheimer's disease in early-onset patients
KR1019970019692A KR970073581A (ko) 1996-05-24 1997-05-21 초로기성 알쯔하이머 질환 치료용 카르니틴 유도체 함유 의약품
ZA9704506A ZA974506B (en) 1996-05-24 1997-05-23 Medicament comprising a carnitine derivative for treating Alzheimer's disease in early-onset patients.
CA002205940A CA2205940A1 (en) 1996-05-24 1997-05-23 Medicament comprising a carnitine derivative for treating alzheimer's disease in early-onset patients
JP9133289A JPH1045582A (ja) 1996-05-24 1997-05-23 アルツハイマー病の早期発病患者を治療するためのカルニチン誘導体を含む医薬
MX9703810A MX9703810A (es) 1996-05-24 1997-05-23 Medicamento que comprende un derivado de carnitinapara tratar la enfermedad de alzheimer en pacientes con inicio prematuro.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000360A IT1284650B1 (it) 1996-05-24 1996-05-24 Farmaco a base di un derivato della carnitina per il trattamento della demenza di alzheimer in pazienti ad insorgenza precoce della patologia

Publications (3)

Publication Number Publication Date
ITRM960360A0 true ITRM960360A0 (it) 1996-05-24
ITRM960360A1 ITRM960360A1 (it) 1997-11-24
IT1284650B1 IT1284650B1 (it) 1998-05-21

Family

ID=11404242

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96RM000360A IT1284650B1 (it) 1996-05-24 1996-05-24 Farmaco a base di un derivato della carnitina per il trattamento della demenza di alzheimer in pazienti ad insorgenza precoce della patologia

Country Status (8)

Country Link
EP (1) EP0808626A1 (it)
JP (1) JPH1045582A (it)
KR (1) KR970073581A (it)
CA (1) CA2205940A1 (it)
IT (1) IT1284650B1 (it)
MX (1) MX9703810A (it)
TW (1) TW473388B (it)
ZA (1) ZA974506B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
ES2323940T3 (es) 2000-05-01 2009-07-28 Accera, Inc. Uso de trigliceridos de cadena media para el tratamiento y prevencion de la enfermedad de alzheimer.
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
EP2500017B1 (en) 2006-04-03 2017-09-06 Accera, Inc. Use of ketogenic compounds for treatment of age-associated memory impairment
PT2650380E (pt) 2007-07-31 2016-01-14 Accera Inc Utilização de testagem genómica e compostos cetogénicos para o tratamento de função cognitiva reduzida
US8597640B2 (en) 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
US8105809B2 (en) 2008-07-03 2012-01-31 Accera, Inc. Enzymatic synthesis of acetoacetate esters and derivatives
CA2729622C (en) 2008-07-03 2017-07-25 Accera, Inc. Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders
SG185692A1 (en) * 2010-06-16 2013-01-30 Sigma Tau Ind Farmaceuti Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
EP2586438A1 (en) 2011-10-28 2013-05-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Compound useful for preventing cognitive deficit disorders in a new born from HIV-seropositive pregnant female who is in treatment with azidothymidine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
EP0340759A1 (en) * 1988-05-06 1989-11-08 MAGIS FARMACEUTICI S.p.A. Salts of O-mono (di)-acetyl-glycero-mono-(bis)-(di)-phosphates of L-acetyl-carnitine and of L-acetyl carnitine esters

Also Published As

Publication number Publication date
IT1284650B1 (it) 1998-05-21
EP0808626A1 (en) 1997-11-26
JPH1045582A (ja) 1998-02-17
ITRM960360A1 (it) 1997-11-24
KR970073581A (ko) 1997-12-10
CA2205940A1 (en) 1997-11-24
MX9703810A (es) 1998-04-30
ZA974506B (en) 1997-12-29
TW473388B (en) 2002-01-21

Similar Documents

Publication Publication Date Title
EP1043991A4 (en) TREATMENT OF ALZHEIMER DISEASE
ITRM960360A0 (it) Farmaco a base di un derivato della carnitina per il trattamento del= la demenza di alzheimer in pazienti ad insorgenza precoce della pato= logia.
NO20011409L (no) Farmasöytiske midler for behandling av Parkinsonssykdom, ADHD og mikroadenomer
NO20001869L (no) FremgangsmÕte for behandling av Alzheimers sykdom
NO911429D0 (no) Stoffbehandling.
PH31643A (en) 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease.
HUP9903213A3 (en) Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease
IS1910B (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
ZA907739B (en) Use of derivative of 1,3,7-trimethylxanthine for the treatment of memory disorders,intellectual disorders of ageing and alzheimer's disese
DK0633879T3 (da) Enantiomert 1-phenyl-2(2-pyridinyl) ethylamin til behandling af neurodegenerative sygdomme
ATE219900T1 (de) Nachttisch
NO911430D0 (no) Stoffbehandlingsmetode.
EP0968716A4 (en) MEDICINES FOR THE TREATMENT OF EYE CIRCULATORY DISORDERS
MX9207407A (es) Mejora de la biodisponibilidad de agentes terapeuticos proteoliticamente labiles.
IT1296613B1 (it) Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide.
IT8848344A0 (it) Dispositivo per il trattamento delle malattie delle gengive
RU95122486A (ru) Средство для лечения тикозных гиперкинезов
ITMI911206A1 (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari a base di vincamina o di un suo sale farmaceuticamente accettabile.
IT8763326V0 (it) Presidio medico per l'elettromagnetoterapia.
IT8519276A0 (it) Procedimento per la fabbricazione di supporti plantari attrezzati, per il trattamento ortesico delle plantalgie, e supporti plantari attrezzati, cosi' ottenuti.
IT1304970B1 (it) Craniostato dotato di mezzi per rilevare l'esatta posizione del pianoincisale di un paziente rispetto ad un piano di riscontro ben definito
EP0955045A4 (en) DRUGS TO FIGHT CERTAIN ANOMALIES OF EYE CIRCULATION
RU95111888A (ru) Способ лечения периферических поражений лицевого нерва
IT9047677A0 (it) Impiego di l-carnitina nel trattamento delle miopatie funzionali laringee.
IT1280629B1 (it) Tripeptide per il trattamento delle forme cancerose, in particolare per il trattamento del melanoma.

Legal Events

Date Code Title Description
0001 Granted